Screener
Climb Bio, Inc. CLYM Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Climb Bio, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
FAQ
- What is Climb Bio, Inc.'s debt-to-equity?
- Climb Bio, Inc. (CLYM) reported debt-to-equity of 0× in Q1 2026.
- How has Climb Bio, Inc.'s debt-to-equity changed year-over-year?
- Climb Bio, Inc.'s debt-to-equity increased by 28.0% year-over-year, from 0× to 0×.
- What is the long-term trend for Climb Bio, Inc.'s debt-to-equity?
- Over 4 years (2021 to 2025), Climb Bio, Inc.'s debt-to-equity has grown at a -10.9% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Climb Bio, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude